Proprietary AI analyst is now available
- Public Comps
- Labo Euromedis
Labo Euromedis Valuation Multiples
Discover revenue and EBITDA valuation multiples for Labo Euromedis and similar public comparables like Observe Medical, Inspira Technologies, Geratherm Medical, ViroGates and more.
Labo Euromedis Overview
About Labo Euromedis
Labo Euromedis is engaged in medical devices. It is engaged in the design, manufacture, rental and export of medical and surgical equipment and products.
Founded
1996
HQ

Employees
21
Website
Financials (FY)
EV
$8M
Valuation Multiples
Start free trialLabo Euromedis Financials
Labo Euromedis reported last fiscal year revenue of $42M and EBITDA of $1M.
In the same fiscal year, Labo Euromedis generated $2M in gross profit, $1M in EBITDA, and had net loss of ($7M).
Revenue (LTM)
Labo Euromedis P&L
In the most recent fiscal year, Labo Euromedis reported revenue of $42M and EBITDA of $1M.
Labo Euromedis is unprofitable as of last fiscal year, with gross margin of 5%, EBITDA margin of 2%, and net margin of (17%).
Financial data powered by Morningstar, Inc.
Labo Euromedis Stock Performance
Labo Euromedis has current market cap of $17M, and enterprise value of $8M.
Market Cap Evolution
Labo Euromedis' stock price is $5.78.
Labo Euromedis share price decreased by 6.4% in the last 30 days, and increased by 13.6% in the last year.
Labo Euromedis has an EPS (earnings per share) of $-2.48.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8M | $17M | -2.5% | -6.4% | 3.9% | 13.6% | $-2.48 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLabo Euromedis Valuation Multiples
Labo Euromedis trades at 0.2x EV/Revenue multiple, and 8.1x EV/EBITDA.
EV / Revenue (LTM)
Labo Euromedis Financial Valuation Multiples
As of June 5, 2026, Labo Euromedis has market cap of $17M and EV of $8M.
Labo Euromedis has a P/E ratio of (2.3x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Labo Euromedis Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Labo Euromedis Margins & Growth Rates
In the most recent fiscal year, Labo Euromedis reported gross margin of 5%, EBITDA margin of 2%, and net margin of (17%).
Labo Euromedis Margins
Labo Euromedis Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Labo Euromedis Operational KPIs
Labo Euromedis' revenue per employee in the last FY averaged $2.0M, while opex per employee averaged $0.0M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Labo Euromedis Competitors
Labo Euromedis competitors include Observe Medical, Inspira Technologies, Geratherm Medical, ViroGates, Bergholm, Ecomiam, Icecure Medical, Advanced Medical, Bionano Genomics and Milton Essex.
Most Labo Euromedis public comparables operate across Medical Devices and Wholesale Distribution.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 9.2x | - | (5.7x) | - | |||
| - | 0.7x | - | (4.4x) | |||
| 0.4x | - | 2.5x | - | |||
| 9.2x | - | (7.9x) | - | |||
| 0.2x | - | 5.8x | - | |||
| 0.3x | 0.3x | (5.3x) | (5.3x) | |||
| 1.9x | 1.4x | (0.4x) | - | |||
| 58723.1x | - | 3467.2x | - | |||
This data is available for Pro users. Sign up to see all Labo Euromedis competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Labo Euromedis
| When was Labo Euromedis founded? | Labo Euromedis was founded in 1996. |
| Where is Labo Euromedis headquartered? | Labo Euromedis is headquartered in France. |
| How many employees does Labo Euromedis have? | As of today, Labo Euromedis has over 21 employees. |
| Is Labo Euromedis publicly listed? | Yes, Labo Euromedis is a public company listed on Euronext Paris. |
| What is the stock symbol of Labo Euromedis? | Labo Euromedis trades under ALEMG ticker. |
| When did Labo Euromedis go public? | Labo Euromedis went public in 2000. |
| Who are competitors of Labo Euromedis? | Labo Euromedis main competitors include Observe Medical, Inspira Technologies, Geratherm Medical, ViroGates, Bergholm, Ecomiam, Icecure Medical, Advanced Medical, Bionano Genomics, Milton Essex. |
| What is the current market cap of Labo Euromedis? | Labo Euromedis' current market cap is $17M. |
| What is the current revenue of Labo Euromedis? | Labo Euromedis' last fiscal year revenue is $42M. |
| What is the current EV/Revenue multiple of Labo Euromedis? | Current revenue multiple of Labo Euromedis is 0.2x. |
| Is Labo Euromedis profitable? | No, Labo Euromedis is not profitable. |
| How many companies Labo Euromedis has acquired to date? | Labo Euromedis hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Labo Euromedis has invested to date? | Labo Euromedis hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Labo Euromedis
Lists including Labo Euromedis
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.